BIOMAT Database Logo BIOMAT Database Logo

[Role of calcium antagonists in the treatment of acute coronary syndromes]. 1996

D Evéquoz

UI MeSH Term Description Entries
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D Evéquoz
InforMatrix: ADP antagonists in acute coronary syndromes.
February 2012, Expert opinion on pharmacotherapy,
D Evéquoz
[Calcium antagonists in acute coronary insufficiency].
January 1978, Bollettino della Societa italiana di cardiologia,
D Evéquoz
Rosuvastatin calcium in acute coronary syndromes.
June 2013, Expert opinion on pharmacotherapy,
D Evéquoz
Angiotensin II receptor antagonists in acute coronary syndromes.
February 2014, European journal of clinical investigation,
D Evéquoz
Glycoprotein IIb/IIIa antagonists in acute coronary syndromes.
November 2001, Haematologica,
D Evéquoz
Glycoprotein IIb/IIIa receptor antagonists in acute coronary syndromes.
June 1999, The Journal of invasive cardiology,
D Evéquoz
The role of aspirin resistance in the treatment of acute coronary syndromes.
January 2008, Clinical cardiology,
D Evéquoz
Is There Still a Role for Glycoprotein IIb/IIIa Antagonists in Acute Coronary Syndromes?
February 2013, Cardiology research,
D Evéquoz
Acute heart failure syndromes: the role of vasopressin antagonists.
January 2009, Acute cardiac care,
D Evéquoz
Calcium channel antagonists in the management of anginal syndromes: changing concepts in relation to the role of coronary vasospasm.
January 1996, Progress in cardiovascular diseases,
Copied contents to your clipboard!